Lysosome liberation inhibitors and histamine release inhibitors
AssigneeMitsubishi Kasei Corporation
InventorsKohei Umezu, Koichiro Hirayama, Kazuo Suzuki
Life of this patent
Estimating the term…
Abstract
The present invention provides lysosome liberation inhibitors comprising, as effective ingredients, cembrane-type diterpene compounds represented by the general formula (I) or (II): ##STR1## wherein R is a hydrogen atom or an acyl group. Also provided is histamine release inhibitors comprising the cembrane-type diterpene compounds represented by the general formula (I) or (II) above as effective ingredients.
Claims7
A method for inhibiting lysosome liberation, which comprises administering to a patient in need thereof an effective amount of a cembrane-type diterpene compound represented by the general formula (I) or (II):
- ##STR3## wherein R is a hydrogen atom or an acyl group.
A method for inhibiting histamine release, which comprises adminstering to a patient in need thereof an effective amount of a cembrane-type diterpene compound represented by the general formula (I) or (II):
- ##STR4## wherein R is a hydrogen atom or an acyl group.
Dependencies are inferred from the claim text.